• 11976 Citations
  • 55 h-Index
1973 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimo Aglietta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cytokine-Induced Killer Cells Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Fetal Blood Medicine & Life Sciences
Granulocyte-Macrophage Colony-Stimulating Factor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1973 2019

  • 11976 Citations
  • 55 h-Index
  • 365 Article
  • 14 Review article
  • 1 Book
  • 1 Chapter

Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program

Martin-Algarra, S., Hinshelwood, R., Mesnage, S., Cebon, J., Ferrucci, P. F., Aglietta, M., Neyns, B., Chiarion-Sileni, V., Lindsay, C. R., Del Vecchio, M., Linardou, H., Merelli, B., Tonini, G., Atkinson, V., Freivogel, K., Stein, D., Dalland, L., Lau, M., Legenne, P., Queirolo, P. & 1 others, Millward, M., May 14 2019, In : Melanoma Research.

Research output: Contribution to journalArticle

Melanoma
Confidence Intervals
Therapeutics
Disease-Free Survival
Fever

Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program

Martin-Algarra, S., Hinshelwood, R., Mesnage, S., Cebon, J., Ferrucci, P. F., Aglietta, M., Neyns, B., Chiarion-Sileni, V., Lindsay, C. R., Del Vecchio, M., Linardou, H., Merelli, B., Tonini, G., Atkinson, V., Freivogel, K., Stein, D., Dalland, L., Lau, M., Legenne, P., Queirolo, P. & 1 others, Millward, M., 2019, In : Melanoma Research. 29, 5, p. 527-532 6 p.

Research output: Contribution to journalArticle

Melanoma
Confidence Intervals
Therapeutics
Disease-Free Survival
Fever
1 Citation (Scopus)

Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line resistant to gemcitabine

Varamo, C., Peraldo-Neia, C., Ostano, P., Basiricò, M., Raggi, C., Bernabei, P., Venesio, T., Berrino, E., Aglietta, M., Leone, F. & Cavalloni, G., Apr 1 2019, In : Cancers. 11, 4, 519.

Research output: Contribution to journalArticle

Open Access
gemcitabine
Cholangiocarcinoma
Cell Line
Doxycycline
Paclitaxel

NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives

Lo Nigro, C., Macagno, M., Sangiolo, D., Bertolaccini, L., Aglietta, M. & Merlano, M. C., Mar 2019, In : Annals of Translational Medicine. 7, 5, p. 105

Research output: Contribution to journalReview article

Antibody-Dependent Cell Cytotoxicity
Natural Killer Cells
Neoplasms
Immunotherapy
Monoclonal Antibodies

"Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer

Rete Oncologica Piemonte e Valle d’Aosta, Jan 2019, In : Critical Reviews in Oncology/Hematology. 133, p. 17-24 8 p.

Research output: Contribution to journalReview article

Pancreatic Neoplasms
Adenocarcinoma
Biological Factors
PubMed
Therapeutics